Price Target Overview of Merck & Co., Inc. (NYSE:MRK)

Marco Green
January 13, 2018

The stock has a market capitalization of $156,280.00, a P/E ratio of 55.63, a P/E/G ratio of 2.84 and a beta of 0.76. The company reported $1.11 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.03 by $0.08. Asset Advisors Corp who had been investing in Merck & Co for a number of months, seems to be less bullish one the $159.44B market cap company. The stock decreased 0.27% or $0.28 during the last trading session, reaching $103.23. About 7.11M shares traded. (NYSE:MRK) has risen 16.86% since January 11, 2017 and is uptrending. It has outperformed by 59.99% the S&P500. Perennial Advisors LLC now owns 1,626 shares of the company's stock valued at $104,000 after purchasing an additional 157 shares during the last quarter. The stock traded with the average Volume of 12.09 Million at the end of last session. PTC Therapeutics, Inc. (NASDAQ:PTCT) has risen 104.51% since January 11, 2017 and is uptrending. It has outperformed by 189.30% the S&P500. MRK was included in 71 notes of analysts from August 13, 2015. One research analyst has rated the stock with a sell rating, eight have given a hold rating and thirteen have given a buy rating to the company's stock. Therefore 75% are positive.

In related news, Chairman Kenneth C. Frazier sold 140,000 shares of the company's stock in a transaction dated Thursday, November 10th. The firm has "Sell" rating by BMO Capital Markets given on Tuesday, July 4. The firm has "Buy" rating by Needham given on Tuesday, October 3. Mount Vernon Associates Md stated it has 0.37% of its portfolio in Merck & Co., Inc. The stock has "Buy" rating by Argus Research on Tuesday, November 17. (NYSE:EDU) on Friday, October 6 with "Buy" rating.

Merck & Co., Inc. has a 12 month low of $53.63 and a 12 month high of $66.80. (NYSE:TGI) on Monday, May 29 with "Buy" rating. The rating was initiated by Jefferies on Wednesday, September 21 with "Hold".

Trilogy Global Advisors Lp, which manages about $14.31B and $1.58 billion US Long portfolio, upped its stake in Yum China Hldgs Inc by 35,412 shares to 3.11M shares, valued at $124.34 million in 2017Q3, according to the filing. It also reduced its holding in Texas Instruments (NASDAQ:TXN) by 287,319 shares in the quarter, leaving it with 246,499 shares, and cut its stake in Time Warner Companies (NYSE:TWX).

As the P/E goes up, it shows that current investor sentiment is that the company is worth more. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.16 and a current ratio of 1.43.

Several other large investors also recently bought and sold shares of MRK. 66 funds opened positions while 377 raised stakes. The Return on Equity (ROE) value stands at 7.2%. The company has market cap of $3.24 billion. (NYSE:MRK). Columbus Circle Invsts holds 0.81% of its portfolio in Merck & Co., Inc. Tennessee-based Pinnacle Fincl has invested 0.28% in Merck & Co., Inc. Solaris Asset Management LLC lifted its position in shares of Merck & Co., 6.3% in the second quarter. Brave Asset Management Incorporated holds 0.77% or 23,003 shares. Icon Advisers Inc Com owns 0.46% invested in Merck & Co., Inc. Jefferies maintained the shares of MRK in report on Thursday, May 25 with "Sell" rating. Candriam Luxembourg S.C.A.'s holdings in Merck & Co., Inc. were worth $37,950,000 at the end of the most recent reporting period. (NYSE:MRK). Meridian Investment Counsel holds 5,059 shares or 0.19% of its portfolio. The company has market cap of $6.45 billion.

Among 30 analysts covering Caterpillar Inc. This showed a surprise of 7.8% in the last quarter earnings. For the next fiscal year, analysts forecast that the firm will post earnings of $4.08 per share, with EPS estimates ranging from $3.92 to $4.33. (NYSE:MRK). New England Private Wealth Ltd Limited Liability Company holds 0.18% or 9,644 shares. Therefore 22% are positive. The company was upgraded on Thursday, January 12 by Morgan Stanley. As per Wednesday, February 24, the company rating was maintained by Wedbush. JPMorgan Chase & Co. set a $70.00 price objective on Merck & Co., Inc. and gave the company a "buy" rating in a report on Sunday, October 29th. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. (NYSE:MRK) has "Outperform" rating given on Tuesday, October 31 by BMO Capital Markets. RBC Capital Markets has "Hold" rating and $10800 target. On Wednesday, April 26 the stock rating was maintained by Jefferies with "Buy". UBS Group decreased their price objective on Merck & Co., Inc. from $72.00 to $67.00 and set a "buy" rating for the company in a report on Monday, October 30th.

Investors sentiment increased to 1.1 in Q3 2017. Its up 5.99, from 1.16 in 2017Q2. It increased, as 50 investors sold CAT shares while 377 reduced holdings. 27 funds opened positions while 69 raised stakes. Arizona State Retirement Systems reported 747,056 shares. Stockholders of record on Friday, December 15th were issued a dividend of $0.48 per share. Invsts Asset Of Georgia Ga Adv, a Georgia-based fund reported 23,012 shares. 401.83 million shares or 0.39% less from 403.41 million shares in 2017Q2 were reported. Institutional investors and hedge funds own 73.63% of the company's stock. (NYSE:RCI) for 216,692 shares. Geode Mgmt Lc invested in 0% or 318,568 shares. Eastern Natl Bank reported 1.01% stake. 16,212 were reported by Cornerstone Limited Liability Co. When analyzing small corporations as possible investments, always it's good to learn who else owns shares. The North Carolina-based Financial Bank Of America Corp De has invested 0% in Owens Realty Mortgage, Inc. (NYSE:RCI). The New York-based Epoch Prns Inc has invested 0% in Rogers Communications Inc. Brown Advisory reported 0.02% stake. Strategic holds 0.74% or 70,235 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Click Lancashire

Discuss This Article